X4P-001
X4P-001-MKKA
Phase 2 small_molecule completed
Quick answer
X4P-001 for WHIM Syndrome is a Phase 2 program (small_molecule) at X4 Pharmaceuticals, Inc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- X4 Pharmaceuticals, Inc
- Indication
- WHIM Syndrome
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed